NeuBase Therapeutics, Inc. Quarterly General and Administrative Expense in USD from Q2 2010 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary: NeuBase Therapeutics, Inc. quarterly/annual General and Administrative Expense history and growth rate from Q2 2010 to Q3 2023.
NeuBase Therapeutics, Inc. General and Administrative Expense for the quarter ending September 30, 2023 was $1.2M, a 46.2% decline year-over-year.
NeuBase Therapeutics, Inc. General and Administrative Expense for the twelve months ending September 30, 2023 was $9.12M, a 23.2% decline year-over-year.
NeuBase Therapeutics, Inc. annual General and Administrative Expense for 2022 was $11.9M, a 2.73% decline from 2021.
NeuBase Therapeutics, Inc. annual General and Administrative Expense for 2021 was $12.2M, a 20.5% increase from 2020.
NeuBase Therapeutics, Inc. annual General and Administrative Expense for 2020 was $10.1M, a 11.3% increase from 2019.

General and Administrative Expense, Trailing 12 Months (USD)

General and Administrative Expense, Quarterly (USD)

General and Administrative Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2023	$9.12M	$1.2M	-$1.03M	-46.2%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$10.2M	$2.4M	-$1.2M	-33.3%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$11.4M	$2.92M	-$176K	-5.7%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$11.5M	$2.6M	-$339K	-11.6%	Oct 1, 2022	Dec 31, 2022	10-QT	2023-06-05
Q3 2022	$11.9M	$2.24M	-$1.13M	-33.6%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	$13M	$3.6M	+$134K	+3.86%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-14
Q1 2022	$12.9M	$3.09M	+$372K	+13.7%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	$12.5M	$2.94M	+$294K	+11.1%	Oct 1, 2021	Dec 31, 2021	10-QT	2023-06-05
Q3 2021	$12.2M	$3.37M	+$871K	+34.9%	Jul 1, 2021	Sep 30, 2021	10-K	2022-12-21
Q2 2021	$11.3M	$3.47M	+$1.14M	+48.9%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	$10.2M	$2.72M	-$17.4K	-0.64%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12
Q4 2020	$10.2M	$2.64M	+$86.8K	+3.4%	Oct 1, 2020	Dec 31, 2020	10-Q	2022-02-11
Q3 2020	$10.1M	$2.5M	-$2.61M	-51.1%	Jul 1, 2020	Sep 30, 2020	10-K	2021-12-23
Q2 2020	$12.7M	$2.33M	+$676K	+40.8%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-13
Q1 2020	$12.1M	$2.74M	+$825K	+43.1%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-14
Q4 2019	$11.2M	$2.55M	+$2.13M	+505%	Oct 1, 2019	Dec 31, 2019	10-Q	2021-02-11
Q3 2019	$9.1M	$5.1M	+$4.41M	+631%	Jul 1, 2019	Sep 30, 2019	10-K	2020-12-23
Q2 2019	$4.69M	$1.66M	+$820K	+98.3%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-13
Q1 2019	$3.87M	$1.91M	+$1.32M	+224%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-14
Q4 2018	$2.55M	$422K	-$1.09M	-72.1%	Oct 1, 2018	Dec 31, 2018	10-Q	2020-03-26
Q3 2018	$3.63M	$699K	-$25K	-3.46%	Jul 1, 2018	Sep 30, 2018	10-K	2019-01-03
Q2 2018	$3.66M	$835K	-$570K	-40.6%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-14
Q1 2018	$4.23M	$591K	-$813K	-57.9%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-15
Q4 2017	$5.04M	$1.51M	-$236K	-13.5%	Oct 1, 2017	Dec 31, 2017	10-Q	2019-02-14
Q3 2017	$5.28M	$724K	-$1.08M	-60%	Jul 1, 2017	Sep 30, 2017	10-K	2019-01-03
Q2 2017	$6.36M	$1.4M	-$261K	-15.7%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-14
Q1 2017	$6.62M	$1.4M	-$1.56M	-52.7%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-15
Q4 2016	$8.18M	$1.75M	+$528K	+43.4%	Oct 1, 2016	Dec 31, 2016	10-Q	2018-02-14
Q3 2016	$7.66M	$1.81M	-$210	-0.01%	Jul 1, 2016	Sep 30, 2016	10-K	2017-12-15
Q2 2016	$7.66M	$1.66M	+$110K	+7.07%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-08
Q1 2016	$7.55M	$2.97M	-$369K	-11.1%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-11
Q4 2015	$7.92M	$1.22M	+$406K	+49.9%	Oct 1, 2015	Dec 31, 2015	10-Q	2017-02-14
Q3 2015	$7.51M	$1.81M	-$298K	-14.2%	Jul 1, 2015	Sep 30, 2015	10-K	2016-12-22
Q2 2015	$7.81M	$1.55M	+$769K	+97.9%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-09
Q1 2015	$7.04M	$3.33M	+$2M	+149%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-10
Q4 2014	$5.04M	$812K	+$755K	+1306%	Oct 1, 2014	Dec 31, 2014	10-Q	2016-02-09
Q3 2014	$4.29M	$2.11M	+$572K	+37.3%	Jul 1, 2014	Sep 30, 2014	10-K	2016-12-22
Q2 2014	$3.72M	$786K	+$647K	+467%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-06
Q1 2014	$3.07M	$1.34M	+$1.3M	+3857%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-11
Q4 2013	$1.76M	$57.8K	-$12.4K	-17.7%	Oct 1, 2013	Dec 31, 2013	10-Q/A	2015-02-10
Q3 2013	$1.78M	$1.53M	+$1.5M	+4091%	Jul 1, 2013	Sep 30, 2013	10-K	2015-12-14
Q2 2013	$279K	$139K	+$108K	+352%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-18
Q1 2013	$171K	$33.8K	-$1.59K	-4.5%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-13
Q4 2012	$173K	$70.2K	+$37.3K	+113%	Oct 1, 2012	Dec 31, 2012	10-Q	2014-02-14
Q3 2012	$136K	$36.6K	+$2.56K	+7.52%	Jul 1, 2012	Sep 30, 2012	10-K	2014-12-22
Q2 2012	$133K	$30.6K	+$12.6K	+70%	Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-13
Q1 2012	$120K	$35.4K	+$12.2K	+52.4%	Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-14
Q4 2011	$108K	$32.9K	+$3.86K	+13.3%	Oct 1, 2011	Dec 31, 2011	10-Q	2013-02-19
Q3 2011	$104K	$34K			Jul 1, 2011	Sep 30, 2011	10-K	2013-01-09
Q2 2011		$18K	-$322K	-94.7%	Apr 1, 2011	Jun 30, 2011	10-Q	2012-08-07
Q1 2011		$23.2K			Jan 1, 2011	Mar 31, 2011	10-Q	2012-05-11
Q4 2010		$29.1K			Oct 1, 2010	Dec 31, 2010	10-Q/A	2012-02-14
Q2 2010		$340K			Apr 1, 2010	Jun 30, 2010	10-Q	2011-08-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.